RxDoctor Payments DataLook up a doctor →

Srikanth Sundaram, MD

Clinical Cardiac Electrophysiology · Littleton, CONPI 1780610543

Payments from drug & device makers

$2,078,094in general payments, 2019–2025

Across 1,173 payments — averaging $1771.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$1.8M
  • Boston Scientific$202K
  • Adagio Medical, Inc.$30K
  • Medtronic$22K
  • Altathera Pharmaceuticals LLC$2K
  • Impulse Dynamics (USA) Inc.$1K
  • plus $3K from 23 others

What the payments were for

  • Consulting fees$332,67968%
  • Speaking & faculty fees$60,22512%
  • Travel & lodging$74,76315%
  • Food & beverage$25,1675%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,078,094 in reported general payments places this provider in the 95th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

See all clinical cardiac electrophysiology providers in Colorado

Medicare billing

Part B allowed, 2024
$346,053
Medicare patients
720
Services billed
3,508

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban666$823,535
XareltoRivaroxaban185$244,968
EntrestoSacubitril/Valsartan32$40,701
JardianceEmpagliflozin25$22,875
Repatha SureclickEvolocumab21$16,504
JanuviaSitagliptin Phosphate12$7,286
Dofetilide31$7,164
Metoprolol Succinate499$6,762
Flecainide Acetate91$4,815
SotalolSotalol Hcl115$2,629
Sucralfate34$2,121
Metoprolol Tartrate310$1,833
Diltiazem 24hr Er (Cd)Diltiazem Hcl81$1,801
Omeprazole78$1,543
Rosuvastatin Calcium116$1,500

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$250$823,535666 claims
Johnson & JohnsonXarelto$26$244,968185 claims
NovartisEntresto$69$40,70132 claims
Boehringer IngelheimJardiance$64$22,87525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 66 clinical cardiac electrophysiology providers in Colorado.

Other clinical cardiac electrophysiology in Littleton

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →